IMRX

$4.57-4.39%

Immuneering Corp

Market Cap

$298M

Sector

Materials

Industry

Biotechnology

Beta

0.36

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

8

recent articles

Analyst Consensus

Strong Buy

13 analysts

Velocity Score

24.83x

Current Rate (90d)

93.72/mo

Baseline Rate

9.38/mo

Unique Buyers (90d)

2

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-23	2026-06-24	Zeskind Benjamin J.	Director & PRESIDENT AND CEO	Purchase	2,400	$4.56	$11K	2.32M	View
2026-06-15	2026-06-16	Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	Purchase	6,035	$4.15	$25K	382.5K	View
2026-01-15	2026-01-16	Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	Purchase	2,298	$4.57	$11K	376.5K	View
2025-06-23	2025-06-24	Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	Purchase	6,007	$2.43	$15K	359.3K	View
2025-06-20	2025-06-24	Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	Purchase	7,415	$2.70	$20K	353.3K	View

Recent News

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

Yahoo Finance · 2026-09-10

Immuneering to Participate in Upcoming Investor Conferences

Yahoo Finance · 2026-09-03

Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients

Yahoo Finance · 2026-08-26

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

Yahoo Finance · 2026-08-05

Informational purposes only, not investment advice.